The Risk of Endocrine Dysfunction and Metabolic Disorders Antipsychotics in Patients with Schizophrenia during Therapy with Second-Generation | Ivanov | Psychiatry (Moscow) (Psikhiatriya)

Psychiatry (Moscow) (Psikhiatriya)
Psychiatry (Moscow)

ISSN 1683-8319 (Print)
ISSN 2618-6667 (Online)

eng | рус

Preview

Psychiatry (Moscow) (Psikhiatriya)

Advanced search

Archives

Download this PDF file

For citations:

Ivanov M.V., Stanovaya V.V., Zaitseva M.M. The Risk of Endocrine Dysfunction and Metabolic Disorders Antipsychotics in Patients with Schizophrenia during Therapy with Second-Generation. Psychiatry (Moscow) (Psikhiatriya). 2025;23(1):39-47. (In Russ.) https://doi.org/10.30629/2618-6667-2025-23-1-39-47

Views PDF (Rus): 11

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1683-8319 (Print)
ISSN 2618-6667 (Online)

* not an advertisement

Подписка на Журнал «ПСИХИАТРИЯ»

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Julia A. Chaika

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

M. V. Ivanov
V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology
Russian Federation

Michail V. Ivanov, Dr. Sci. (Med.), Professor, Chief scientific оfficer, Head of the Department, Department of Biological Therapy for Mentally ill

Saint Petersburg

V. V. Stanovaya
V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology
Russian Federation

Victoria V. Stanovaya, junior researcher, Department of Biological Therapy for Mentally ill

Saint Petersburg

M. M. Zaitseva
V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology
Russian Federation

Marina M. Zaitseva, laboratory assistant researcher, Department of Biological Therapy for Mentally ill

Saint Petersburg

Notifications